{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:14:54Z","timestamp":1769598894099,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,11,15]],"date-time":"2004-11-15T00:00:00Z","timestamp":1100476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,11,15]],"date-time":"2004-11-15T00:00:00Z","timestamp":1100476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2005,1,1]]},"DOI":"10.1038\/sj.bmt.1704728","type":"journal-article","created":{"date-parts":[[2004,11,15]],"date-time":"2004-11-15T10:20:07Z","timestamp":1100514007000},"page":"159-164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients"],"prefix":"10.1038","volume":"35","author":[{"given":"M","family":"Krejci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Buchler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Hajek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Svobodnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Krivanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Pour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Vorlicek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,11,15]]},"reference":[{"key":"BF1704728_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/canjclin.50.1.7","volume":"50","author":"RT Greenlee","year":"2000","unstructured":"Greenlee RT, Murray T, Bolden S, Wingo PA . Cancer statistics, 2000. CA Cancer J Clin 2000; 50: 7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"BF1704728_CR2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","volume":"36","author":"B Durie","year":"1975","unstructured":"Durie B, Salmon S . A clinical staging system for multiple myeloma. Cancer 1975; 36: 842\u2013854.","journal-title":"Cancer"},{"key":"BF1704728_CR3","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1182\/blood.V81.12.3382.3382","volume":"87","author":"P Greipp","year":"1993","unstructured":"Greipp P, Lust JA, O'Fallon WM et al. Plasma cell labelling index and beta2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood 1993; 87: 3382\u20133387.","journal-title":"Blood"},{"key":"BF1704728_CR4","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/bjc.1996.212","volume":"73","author":"G Grignani","year":"1996","unstructured":"Grignani G, Gobbi PG, Formisano R et al. A prognostic index for multiple myeloma. Brit J Cancer 1996; 73: 1101\u20131107.","journal-title":"Brit J Cancer"},{"key":"BF1704728_CR5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1182\/blood.V85.2.448.448","volume":"89","author":"JF San Miguel","year":"1995","unstructured":"San Miguel JF, Garcia-Sanz R, Gonzales M et al. A new staging system for multiple myeloma based on the number of S-phase plasma cells. Blood 1995; 89: 448\u2013455.","journal-title":"Blood"},{"issue":"Suppl. 1","key":"BF1704728_CR6","first-page":"42","volume":"4","author":"PR Greipp","year":"2003","unstructured":"Greipp PR, San Miguel JF, Fonsenca R et al. Development of an International Prognostic Index for myeloma: report of the International Myeloma Working Group. Hematol J 2003; 4 (Suppl. 1): 42 (Abstr. P7.1).","journal-title":"Hematol J"},{"key":"BF1704728_CR7","first-page":"190a","volume":"102","author":"PR Greipp","year":"2003","unstructured":"Greipp PR, Miguel JF, Durie BG et al. New International Staging System (ISS) for multiple myeloma from the International Myeloma Working Group. Blood 2003; 102: 190a (Abstr. 664).","journal-title":"Blood"},{"key":"BF1704728_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harrousseau JL, Stopa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 1996; 335: 91\u201397.","journal-title":"N Engl J Med"},{"key":"BF1704728_CR9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V89.3.789","volume":"89","author":"B Barlogie","year":"1997","unstructured":"Barlogie B, Jagannath S, Vesole DH et al. Superiority of tandem transplantation over standard therapy for previously untreated multiple myeloma. Blood 1997; 89: 789\u2013793.","journal-title":"Blood"},{"key":"BF1704728_CR10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1182\/blood.V93.1.55","volume":"93","author":"B Barlogie","year":"1999","unstructured":"Barlogie B, Jagannath S, Desikan KR et al. Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood 1999; 93: 55\u201365.","journal-title":"Blood"},{"key":"BF1704728_CR11","first-page":"7","volume":"95","author":"S Lenhoff","year":"2000","unstructured":"Lenhoff S, Hjorth M, Holmberg E et al. Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study group. Blood 2000; 95: 7\u201311.","journal-title":"Blood"},{"key":"BF1704728_CR12","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"JA Child","year":"2003","unstructured":"Child JA, Morgan GJ, Davies FE et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875\u20131883.","journal-title":"N Engl J Med"},{"key":"BF1704728_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/ajh.2830480201","volume":"48","author":"T Facon","year":"1995","unstructured":"Facon T . Prognostic factors in low tumours mass asymptomatic multiple myeloma. Am J Hematol 1995; 48: 71\u201375.","journal-title":"Am J Hematol"},{"issue":"Suppl. 1","key":"BF1704728_CR14","first-page":"190","volume":"4","author":"R Hajek","year":"2003","unstructured":"Hajek R, Scudla V, Krejci M et al. Interim analysis of randomized trial 4W of Czech Myeloma Group: maintenance therapy interferon alpha or sequential maintenance therapy interferon alpha and dexamethasone after high-dose chemotherapy and peripheral blood stem cell transplantation in newly diagnosed patients with multiple myeloma. Hematol J 2003; 4 (Suppl. 1): 190 (Abstr. 230).","journal-title":"Hematol J"},{"key":"BF1704728_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/sj.thj.6200312","volume":"4","author":"BGM Durie","year":"2003","unstructured":"Durie BGM, Kyle RA, Belch A et al. Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol J 2003; 4: 379\u2013398.","journal-title":"Hematol J"},{"key":"BF1704728_CR16","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","volume":"102","author":"J Blade","year":"1998","unstructured":"Blade J, Samson D, Reece D et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. Br J Haematol 1998; 102: 1115\u20131123.","journal-title":"Br J Haematol"},{"key":"BF1704728_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-2141.2002.03231.x","volume":"116","author":"G Tricot","year":"2002","unstructured":"Tricot G, Spencer T, Sawyer J et al. Predicting long-term (\u2a7e5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants. Br J Haematol 2002; 116: 211\u2013217.","journal-title":"Br J Haematol"},{"key":"BF1704728_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1023\/A:1008252227512","volume":"8","author":"H Goldschmidt","year":"1997","unstructured":"Goldschmidt H, Hegenbert U, Wallmeier M et al. High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma. Ann Oncol 1997; 8: 243\u2013246.","journal-title":"Ann Oncol"},{"key":"BF1704728_CR19","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1182\/blood.V84.3.950.950","volume":"84","author":"DH Vesole","year":"1994","unstructured":"Vesole DH, Barlogie B, Jagannath S et al. High dose therapy for refractory multiple myeloma: Improved prognosis with better supportive care and double transplants. Blood 1994; 84: 950\u2013956.","journal-title":"Blood"},{"key":"BF1704728_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/sj.bmt.1703818","volume":"31","author":"E Terpos","year":"2003","unstructured":"Terpos E, Apperley JF, Samson D et al. Autologous stem cell transplantation in multiple myeloma: improved survival in non secretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients. Bone Marrow Transplant 2003; 31: 163\u2013170.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704728_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/sj.bmt.1701062","volume":"21","author":"A Alegre","year":"1998","unstructured":"Alegre A, Diaz-Mediavilla J, San-Miguel J et al. Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from Spanish Registry. Bone Marrow Transplant 1998; 21: 133\u2013140.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704728_CR22","first-page":"52","volume":"85","author":"M Tribalto","year":"2000","unstructured":"Tribalto M, Amadori S, Cudillo L et al. Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter Study. Haematologica 2000; 85: 52\u201358.","journal-title":"Haematologica"},{"key":"BF1704728_CR23","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1182\/blood.V88.12.4711.bloodjournal88124711","volume":"88","author":"B Bjorkstrand","year":"1996","unstructured":"Bjorkstrand B, Ljungman P, Svensson H et al. Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation. Blood 1996; 88: 4711\u20134718.","journal-title":"Blood"},{"key":"BF1704728_CR24","first-page":"844","volume":"84","author":"I Majolino","year":"1999","unstructured":"Majolino I, Vignetti M, Meloni G et al. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Haematologica 1999; 84: 844\u2013852.","journal-title":"Haematologica"},{"key":"BF1704728_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0037-1963(01)90013-7","volume":"38","author":"B Bjorkstrand","year":"2001","unstructured":"Bjorkstrand B . European Group for Blood and Marrow Transplantation Registry studies in multiple myeloma. Semin Hematol 2001; 38: 219\u2013225.","journal-title":"Semin Hematol"},{"key":"BF1704728_CR26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood.V93.1.51","volume":"93","author":"DS Siegel","year":"1999","unstructured":"Siegel DS, Desikan KR, Mehta J et al. Age is not a prognostic variable with autotransplants for multiple myeloma. Blood 1999; 93: 51\u201354.","journal-title":"Blood"},{"key":"BF1704728_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/sj.bmt.1702188","volume":"25","author":"B Sirohi","year":"2000","unstructured":"Sirohi B, Powles R, Treleaven J et al. The role of autologous transplantation in patients with multiple myeloma aged 65 years and over. Bone Marrow Transplant 2000; 25: 533\u2013539.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704728_CR28","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/sj.bmt.1703254","volume":"28","author":"DH Vesole","year":"2001","unstructured":"Vesole DH, Simic A, Lazarus HM . Controversy in multiple myeloma transplants: a tandem autotransplants and mini-allografts. Bone Marrow Transplant 2001; 28: 725\u2013735.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704728_CR29","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1365-2141.1994.tb06731.x","volume":"87","author":"MA Dimopoulos","year":"1994","unstructured":"Dimopoulos MA, Hester J, Huh Y et al. Intensive chemotherapy with blood progenitor transplantation for primary resistant multiple myeloma. Br J Haematol 1994; 87: 730\u2013734.","journal-title":"Br J Haematol"},{"key":"BF1704728_CR30","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1182\/blood.V84.12.4278.bloodjournal84124278","volume":"84","author":"R Alexanian","year":"1994","unstructured":"Alexanian R, Dimopoulos MA, Hester J et al. Early myeloablative therapy for multiple myeloma. Blood 1994; 84: 4278\u20134282.","journal-title":"Blood"},{"key":"BF1704728_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3109\/07357909609012166","volume":"14","author":"DH Vesole","year":"1996","unstructured":"Vesole DH, Jagannath S, Tricot G et al. Autologous bone marrow and peripheral blood stem cell transplantation in multiple myeloma. Cancer Invest 1996; 14: 378\u2013391.","journal-title":"Cancer Invest"},{"key":"BF1704728_CR32","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1200\/JCO.1999.17.7.2173","volume":"17","author":"DH Vesole","year":"1999","unstructured":"Vesole DH, Crowley JJ, Catchatourian R et al. High-dose melphalan with autotransplantation for refractory multiple myeloma: results of a Southwest Oncology Group phase II trial. J Clin Oncol 1999; 17: 2173\u20132179.","journal-title":"J Clin Oncol"},{"key":"BF1704728_CR33","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/sj.bmt.1702640","volume":"26","author":"SV Rajkumar","year":"2000","unstructured":"Rajkumar SV, Fonseca R, Dispenzieri A et al. Effect of complete response on outcome following autologous stem cell transplantation for myeloma. Bone Marrow Transplant 2000; 26: 979\u2013983.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704728_CR34","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/sj.bmt.1701182","volume":"21","author":"B Barlogie","year":"1998","unstructured":"Barlogie B, Jagannath S, Naucke S et al. Long-term follow-up after high-dose therapy for high-risk multiple myeloma. Bone Marrow Transplant 1998; 21: 1101\u20131107.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl. 1","key":"BF1704728_CR35","first-page":"100","volume":"23","author":"B Bjorkstrand","year":"1999","unstructured":"Bjorkstrand B, Svensson H, Goldschmidt H et al. Autologous stem cell transplantation in multiple myeloma \u2013 the 1999 EBMT registry update. Bone Marrow Transplant 1999; 23 (Suppl. 1): 100 (Abstr. 435).","journal-title":"Bone Marrow Transplant"},{"key":"BF1704728_CR36","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood.V88.3.838.838","volume":"88","author":"DH Vesole","year":"1996","unstructured":"Vesole DH, Tricot G, Jagannath S et al. Autotransplants in mutiple myeloma: what have we learned? Blood 1996; 88: 838\u2013847.","journal-title":"Blood"},{"key":"BF1704728_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0268-960X(02)00043-7","volume":"16","author":"JL Harousseau","year":"2002","unstructured":"Harousseau JL, Attal M . The role of stem cell transplantation in multiple myeloma. Blood Rev 2002; 16: 245\u2013253.","journal-title":"Blood Rev"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704728","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704728.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704728.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:41:08Z","timestamp":1648078868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,15]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,1,1]]}},"alternative-id":["BF1704728"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704728","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,15]]},"assertion":[{"value":"29 March 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}